{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-168285","form_type":"8-K","ticker":"PMVP","cik":"0001699382","company_name":"PMV Pharmaceuticals, Inc.","filed_at":"2022-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.889959+00:00","generated_at":"2026-06-25T04:24:13.272167+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"PMV Pharma stockholders re-elect Levine and Baum, approve say-on-pay and one-year frequency, ratify EY","bullets":["Arnold Levine elected as Class II director with 29,469,991 FOR votes; Charles Baum with 29,134,747 FOR.","Non-binding say-on-pay approved: 32,962,908 FOR, 872,088 AGAINST.","Stockholders favored one-year frequency for future advisory votes on executive compensation (33,827,318 FOR one year).","Ernst & Young ratified as independent auditor for FY2022: 35,746,657 FOR, 4,223 AGAINST, 451 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-168285","json":"https://secwatch.observer/filing/0001193125-22-168285.json","markdown":"https://secwatch.observer/filing/0001193125-22-168285.md","text":"https://secwatch.observer/filing/0001193125-22-168285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/0001193125-22-168285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699382/000119312522168285/d274679d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:24:13.272167+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}